Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 91,140 | 83,841 | 70,284 | 45,250 | 42,143 |
| Cost of Goods | 4,949 | 6,684 | 6,009 | 2,419 | 2,871 |
| Gross Profit | 86,191 | 77,157 | 64,275 | 42,831 | 39,272 |
| Operating Expenses | 45,746 | 55,369 | 55,718 | 49,934 | 36,896 |
| Operating Income | 41,394 | 22,472 | 8,566 | -6,684 | 3,247 |
| Other Income | 7,216 | 7,297 | 7,479 | 7,616 | 7,410 |
| Pre-tax Income | 48,610 | 29,769 | 16,045 | 932 | 10,657 |
| Income Tax | 3,131 | 2,589 | 477 | N/A | N/A |
| Net Income Continuous | 45,479 | 27,180 | 15,568 | 932 | 8,692 |
| Net Income | $45,479 | $27,180 | $15,568 | $932 | $8,692 |
| EPS Basic Total Ops | 1.60 | 0.95 | 0.54 | 0.03 | 0.53 |
| EPS Basic Continuous Ops | 1.59 | 0.95 | 0.54 | 0.03 | 0.53 |
| EPS Diluted Total Ops | 1.53 | 0.91 | 0.53 | 0.03 | 0.61 |
| EPS Diluted Continuous Ops | 1.53 | 0.91 | 0.53 | 0.03 | 0.61 |
| EPS Diluted Before Non-Recurring Items | 1.52 | 0.91 | 0.86 | N/A | N/A |
| EBITDA(a) | $42,949 | $24,001 | $10,587 | $-5,075 | $5,004 |